GOSSAMER BIO, INC. (GOSS)
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman
IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman
COTY INVESTOR UPDATE: Coty Inc. (COTY) Sued After Surprise Profit Decline, CEO Exit, and Withdrawn 2026 Guidance -- Hagens Berman